Related Experiment Video

Updated: Aug 25, 2026

Intravenous Injections in Neonatal Mice
05:17

Intravenous Injections in Neonatal Mice

Published on: November 11, 2014

What is the appropriate intravenous dose of vitamin E for very-low-birth-weight infants?

Luc P Brion1, Edward F Bell, Talkad S Raghuveer

  • 1Albert Einstein College of Medicine, Children's Hospital at Montefiore, Bronx, NY 10461-2373, USA.

Journal of Perinatology : Official Journal of the California Perinatal Association
|April 7, 2004
PubMed

Insights

Vitamin E supplementation above 3.5 mg/dl may reduce severe retinopathy in very-low-birth-weight infants but increases sepsis risk. Adjusted dosing is recommended over fixed doses for better safety and efficacy.

Area of Science:

  • Neonatology
  • Nutritional Science
  • Pediatric Ophthalmology

Background:

  • The American Academy of Pediatrics (AAP) defines normal serum tocopherol levels as 1-2 mg/dl.
  • Vitamin E is crucial for infant health, particularly for very-low-birth-weight (VLBW) infants.

Purpose of the Study:

  • To evaluate the efficacy and safety of vitamin E supplementation in VLBW infants.
  • To determine optimal dosing strategies for vitamin E to prevent retinopathy of prematurity.

Main Methods:

  • Systematic review of Cochrane studies on vitamin E supplementation in VLBW infants.
  • Analysis of serum tocopherol levels in relation to clinical outcomes.
  • Comparison of fixed versus weight-adjusted intravenous vitamin E dosing.

Main Results:

  • Vitamin E levels >3.5 mg/dl significantly reduced severe retinopathy risk but increased sepsis and necrotizing enterocolitis risk with treatment >1 week.
  • Fixed daily intravenous doses showed an inverse relationship with birth weight, risking both low and high serum levels.
  • Weight-adjusted dosing appears more appropriate than fixed daily doses.

Conclusions:

  • Vitamin E supplementation requires careful dose adjustment based on infant weight.
  • Current recommendations suggest 2 ml/kg/day of MVI Pediatric (2.8 IU/kg/day) for VLBW infants, with a maximum dose.
  • Further research may refine vitamin E protocols for VLBW infants to balance benefits and risks.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
IV Infusion to Oral Dosing: Conversion Methods01:28

IV Infusion to Oral Dosing: Conversion Methods

The development of extended-release formulations has facilitated the transition from intravenous to oral medication, offering a more convenient and patient-friendly approach to drug administration. This transition, however, requires careful management to ensure that therapeutic drug levels are maintained, preserving efficacy and avoiding adverse effects. Understanding pharmacokinetic principles and dosage calculations is critical during this process.Pharmacokinetics of the...
Dosage Regimen: Multiple Oral Dosage01:25

Dosage Regimen: Multiple Oral Dosage

Understanding how a drug's concentration fluctuates within the body over time is crucial in pharmacokinetics, particularly with multiple oral doses. A graphical representation of multiple oral dosages provides insight into these dynamics. Typical accumulation curves of a drug's concentration in the body reveal a sawtooth pattern, indicating periodic peaks and troughs correlating with each dose administration and the drug's subsequent elimination.The plasma concentration at any time during an...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Dosage Interval and Administration Route: Determination Methods01:19

Dosage Interval and Administration Route: Determination Methods

A medication’s effectiveness largely depends on its appropriate dosage and the route of administration. Dosage ensures that a sufficient drug concentration is maintained in the bloodstream to elicit the desired therapeutic effect without causing toxicity. The route of administration affects the drug's bioavailability, rate of absorption, and onset of action, which are crucial for achieving optimal therapeutic outcomes. Drug dosage calculations are critical to tailoring therapy to individual...
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...